Patients with osteoarthritis or rheumatoid arthritis who take ibuprofen are more likely to experience an increase in systolic blood pressure than those taking celecoxib, results of the PRECISION-ABPM study suggest.
The number of people with elevated systolic blood pressure and the number of associated deaths have “increased substantially” in the past 25 years, results from the Global Burden of Disease, Injuries, and Risk Factors 2015 study suggest.
The number of people living with high blood pressure has almost doubled worldwide over the past 4 decades, with the biggest rise in low- and middle-income countries, according to an analysis of data from 19.1 million people.
Research shows that low diastolic blood pressure is a marker of subclinical cardiac damage and increased coronary heart disease risk, particularly in patients with relatively high systolic blood pressure.
Long-term variability in blood pressure, measured in the clinic, is associated with an increased risk of cardiovascular disease events and mortality, regardless of mean blood pressure, results of a systematic review and meta-analysis show.
Nearly one-third of the world’s adult population had hypertension in 2010, with prevalence higher in low- and middle-income countries than in high-income countries for the first time in history, researchers report.